论文部分内容阅读
应用双抗体夹心ＥＬＩＳＡ 法检测３８ 例晚期肺癌患者参麦注射液治疗前后血清可溶性白细胞介素－２ 受体（ＳＩＬ－２Ｒ）水平。结果治疗前ＳＩＬ－２Ｒ 水平明显高于对照组，治疗后血清ＳＩＬ－２Ｒ 水平较治疗前显著降低，且治疗后血清ＳＩＬ－２Ｒ 水平与对照组比较无明显差异。提示参麦注射液对晚期肺癌患者免疫功能有调节作用。
The level of serum soluble interleukin-2 receptor (SIL-2R) in 38 patients with advanced lung cancer before and after treatment with Shenmai injection was detected by double antibody sandwich ELISA. Results The level of SIL-2R before treatment was significantly higher than that of the control group. The level of serum SIL-2R after treatment was significantly lower than before treatment, and there was no significant difference in serum SIL-2R levels after treatment between the two groups. It is suggested that Shenmai injection can regulate the immune function of patients with advanced lung cancer.